NFKB1 and cancer: Inflammation has been shown to be a key factor in promoting tumorigenesis primarily through the NF-κB pathway, which is activated in response to proinflammatory cytokines such as TNF the increased levels of which are strongly associated with the aggressive phenotype of various cancers (48).